A new technique in prostate cancer treatment has recently been developed – the combination of focal laser ablation and magnetic resonance imaging (MRI). This new treatment option promises to be a safe and effective method for treating prostate cancer and is offered at our prostate cancer treatment center.
Detecting prostate cancer
Being the second-leading cause of deaths in American men who have cancer, prostate cancer has long been the talk of the town because of the methods by which it is diagnosed in patients. Typically, the patients will undergo a prostate-specific antigen exam and, later on, a biopsy of a sample tissue from the prostate gland.
Treatment options for prostate cancer patients range from the surgical removal of the prostate to an active surveillance of the disease’s progress.
In search for less aggressive options
New methods for more accurate detection of cancers have been discovered, which could possibly spare patients from repeated, unnecessary biopsies, treatments, and surgeries. Focal laser ablation therapy is that less invasive treatment that could target and destroy cancer precisely.
A clinical trial has been initiated to evaluate the safety and feasibility of the MRI-guided focal laser ablation method for the treatment of low-risk prostate cancer. The new technique gives the ablation treatment more advantage because the guidance of the MRI allows direct visualization, thus targeting the prostate tumors accurately.
For more information on focal laser ablation, contact us at the Sperling Prostate Cancer Center by calling (877) 605-2737. You can also fill out this online contact form to get in touch with us. We look forward to hearing from you!
NOTE: This content is solely for purposes of information and does not substitute for diagnostic or medical advice. Talk to your doctor if you are experiencing pelvic pain, or have any other health concerns or questions of a personal medical nature.
About Dr. Dan Sperling
Dan Sperling, MD, DABR, is a board certified radiologist who is globally recognized as a leader in multiparametric MRI for the detection and diagnosis of a range of disease conditions. As Medical Director of the Sperling Prostate Center, Sperling Medical Group and Sperling Neurosurgery Associates, he and his team are on the leading edge of significant change in medical practice. He is the co-author of the new patient book Redefining Prostate Cancer, and is a contributing author on over 25 published studies. For more information, contact the Sperling Prostate Center.
